Patent · US Active

LXR agonists and uses thereof

US10669296B2 · kind B2 · utility

5Cited by

16References

19Claims

0Family size

Assignee

Rgenix, Inc. · US

Inventors

Eduardo J. Martinez · Bryn Mawr, US
Bernd Kaiser · Plainsboro, US
Sohail Tavazoie · New York, US
Isabel Kurth · New York, US
Foster Gonsalves · Brooklyn, US
David M. Darst, Jr. · New York, US
Masoud Tavazoie · New York, US

Key dates

Filing date	Jan 9, 2015
Grant date	Jun 2, 2020
Priority date	—
Expiry date	Jan 9, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2601/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention features compounds that modulate the activity of liver X receptors, pharmaceutical compositions including the compounds of the invention, and methods of utilizing those compositions for modulating the activity of liver X receptors in the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.